Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;45(9):e2300088.
doi: 10.1002/bies.202300088. Epub 2023 Jul 4.

Defining bone fide effectors of RAS GTPases

Matthew J Smith  1   2
Affiliations
Review

Defining bone fide effectors of RAS GTPases

Matthew J Smith. Bioessays. 2023 Sep.

Abstract

RAS GTPases play essential roles in normal development and are direct drivers of human cancers. Three decades of study have failed to wholly characterize pathways stimulated by activated RAS, driven by engagement with 'effector' proteins that have RAS binding domains (RBDs). Bone fide effectors must bind directly to RAS GTPases in a nucleotide-dependent manner, and this interaction must impart a clear change in effector activity. Despite this, for most proteins currently deemed effectors there is little mechanistic understanding of how binding to the GTPase alters protein function. There has also been limited effort to comprehensively resolve the specificity of effector binding to the full array of RAS superfamily GTPase proteins. This review will summarize what is known about RAS-driven activation for an array of potential effector proteins, focusing on structural and mechanistic effects and highlighting how little is still known regarding this key paradigm of cellular signal transduction.

Keywords: AFDN; PI3K; RAF; RAS GTPases; RBD domain; SCRIB; adherens junctions.

PubMed Disclaimer

References

REFERENCES

    1. Fernández-Medarde, A., & Santos, E. (2011). Ras in cancer and developmental diseases. Genes & Cancer, 2(3), 344-358. https://doi.org/10.1177/1947601911411084
    1. Malumbres, M., & Barbacid, M. (2003). RAS oncogenes: The first 30 years. Nature Reviews Cancer, 3(6), 708-708. https://doi.org/10.1038/nrc1193
    1. Buday, L., & Downward, J. (2008). Many faces of Ras activation. Biochimica et Biophysica Acta, 1786(2), 178-187. https://doi.org/10.1016/j.bbcan.2008.05.001
    1. Vetter, I. R., & Wittinghofer, A. (2001). The guanine nucleotide-binding switch in three dimensions. Science, 294(5545), 1299-1304. https://doi.org/10.1126/science.1062023
    1. Filchtinski, D., Sharabi, O., Rüppel, A., Vetter, I. R., Herrmann, C., & Shifman, J. M. (2010). What makes Ras an efficient molecular switch: A computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf. Journal of Molecular Biology, 399(3), 422-435. https://doi.org/10.1016/j.jmb.2010.03.046

Publication types

LinkOut - more resources